A bioactive biflavonoid from Campnosperma panamense.

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Parasitology

Background:

• Biflavonoids are a class of natural products with diverse biological activities.
• Campnosperma panamense is a plant source of potentially bioactive compounds.
• Protozoal infections like malaria and leishmaniasis remain significant global health challenges.

Purpose of the Study:

• To isolate and characterize lanaroflavone, a biflavonoid from Campnosperma panamense.
• To evaluate the in vitro antiprotozoal activity of lanaroflavone.
• To determine the efficacy of lanaroflavone against malaria, leishmaniasis, and Chagas disease parasites.

Main Methods:

• Isolation of lanaroflavone using bioguided fractionation of the methanol extract from Campnosperma panamense aerial parts.
• In vitro assessment of antiprotozoal activity against relevant parasitic species.
• Testing against Plasmodium falciparum (malaria), Leishmania species (leishmaniasis), and Trypanosoma cruzi (Chagas disease).

Main Results:

• Lanaroflavone was successfully isolated and identified as a biflavonoid.
• The compound exhibited significant in vitro antimalarial activity.
• Lanaroflavone also displayed in vitro leishmanicidal activity.
• No activity was observed against Trypanosoma cruzi, the causative agent of Chagas disease.

Conclusions:

• Lanaroflavone is a promising natural product with potential therapeutic applications against malaria and leishmaniasis.
• Further investigation into the mechanism of action and structure-activity relationship of lanaroflavone is warranted.
• Lanaroflavone is not a viable candidate for Chagas disease treatment based on current findings.